Resources on COVID-19 and drug markets

The EMCDDA is producing a series of special reports and briefings on the impact of the COVID-19 pandemic on drug markets.

Metadata
Provider: 
ECEC
URL: 
https://www.emcdda.europa.eu/publications/ad-hoc-publication/covid-19-and-drug-markets-resource-page_enhttps://www.emcdda.europa.eu/publications/ad-hoc-publication/covid-19-and-drug-markets-resource-page_en
Retrieved on: 
Saturday, May 30, 2020
Information
Tags: 
Agencies of the European Union, Organizations, Government agencies, Government, Crypto-anarchism, Darknet market, Illegal drug trade, European Monitoring Centre for Drugs and Drug Addiction, Europol, Market, European Union
Summary
Key Points: 
  • The EMCDDA is producing a series of special reports and briefings on the impact of the COVID-19 pandemic on drug markets.
  • Top of page

    EMCDDA publications

    The effect of COVID-19 on drug markets in the EU

    The effect COVID-19 is having on the EU's largest criminal marke is explored inEU Drug Markets: Impact of COVID-19, produced jointly with Europol.

  • In a special report, Drug supply via darknet markets, we explore whether established methods of drug supply and distribution to consumers have changed during recent restrictions on movement (read the accompanying news release).
  • Top of page

    Related resources

    You may find below some useful resources related to COVID-19 and drug markets.

Copyright: 
2020 EC. All Rights Reserved.